Skip to main content
  • 2017 Acquisition

    Sienna Capital : new commitment in Backed 1 LP

    On 29 September 2017, Sienna Capital committed EUR 25 million in Backed 1 LP (« Backed »), a venture capital fund based in London, specialized in the sector of new digital technologies.

  • 2017 Acquisition

    Distribution of EUR 100 million by Kartesia's KCO III fund

    At 30 September 2017, Kartesia’s KCO III fund is fully invested and distributed a total amount of EUR 100 million, representing around 21% of the called capital.

  • 2017 Acquisition

    Acquisition by ECP III of a majority stake in Keesing Media Group

    In September 2017, ECP III acquired a majority stake in Keesing Media Group (« Keesing »), the leading European publisher of games and puzzle magazines, from Telegraaf Media Group. The acquisition price for ECP III amounts to EUR 34 million.

  • 2017 Acquisition

    Investment in GEA Group

    GEA Group (« GEA ») announced on 3 August 2017 that GBL had crossed the 3.0% threshold in the voting rights of the company. GEA is a worldwide leader in the supply of equipment and project management for a wide range of processing industries. Its technology focuses on components and production processes for various markets, notably in the Food & Beverage sectors. At 30 September 2017, GBL holds 3.1% of the capital, representing a market value of EUR 233 million.

  • 2017 Acquisition

    Strengthening of the position in Burberry

    Reinforcement of the shareholding in Burberry, from 2.95% at year-end 2016 to 4% at end of September 2017, for a market value of EUR 352 million

  • 2017 Sale

    Sale by ECP III to PAI Partners of its majority stake in ELITech

    In July 2017, ECP III sold to PAI Partners its majority stake in ELITech, a manufacturer of specialty in-vitro diagnostics equipment and reagents. This transaction generated a net consolidated capital gain on disposal of EUR 104 million (GBL’s share).

  • 2017 Acquisition

    Expected performance of KCO III in line with target returns

    At 30 June 2017, Kartesia Credit Opportunities (KCO III) is now fully invested in primary and secondary transactions and has distributed to its investors a total amount of EUR 84 million, representing c.18% of capital called

  • 2017 Acquisition

    Acquisition of Xeris & Ivantis

    • Acquisition by Mérieux Participations II (MP II) of a minority stake in Xeris Pharmaceuticals Inc. : biopharmaceutical company developing injectable therapeutics for  multiple indications including diabetes
    • Acquisition by MP II of a minority stake in Ivantis Inc., a company dedicated to the development of new and innovative solutions for glaucoma

  • 2017 Sale

    Disposal of ELITech

    • ECP III reached an agreement with PAI Partners for the sale of ELITech Group, a manufacturer of specialty in-vitro diagnostics equipment and reagents
    • Estimated net consolidated capital gain on disposal of EUR 102 million (GBL’s share)

  • 2017

    Success of the inaugural institutional bond issue

    • EUR 500 million bond issue, with a coupon of 1.375% and maturing on 23 May 2024
    • Issuance allowing GBL to reinforce its liquidity profile, lengthen the debt maturity profile from 1.3 years at year-end 2016 to 3.5 years at end of June 2017 and further diversify its financing sources by successfully establishing the group’s credit quality on the institutional bond market
    • Oversubscription of almost 3 times by a diversified base of primarily French, Belgian and Anglo-Saxon institutional investors

  • 2017 Acquisition

    Equity investment in Parques Reunidos

    On 12 April 2017, GBL announced the acquisition of a 15.0% participation in the capital of Parques Reunidos Servicios Centrales, S.A. (« Parques Reunidos »). Listed on the Madrid stock exchange, Parques Reunidos is a reference operator of leisure parks in Europe, North America and Asia. On 25 April 2017, Parques Reunidos co-opted a representative of GBL in the Board of Directors. At 30 September 2017, GBL holds 15.2% of the capital, representing a market value of EUR 157 million.

  • 2017 Acquisition

    Participation of GBL in the capital increase of Ontex

    In March 2017, GBL participated in the capital increase of Ontex that aims to refinance the company following the acquisition of the “hygienic consumables” activity of Hypermarcas. Following this operation, the holding percentage of GBL remains unchanged at 19.98%. Furthermore, the appointment of Michael Bredael as the GBL representative to the Board of Directors will be proposed to the General Shareholders’ Meeting of Ontex of 24 May.

  • 2017 Acquisition

    Investment in Burberry

    On 28 February 2017, Burberry Group Plc (« Burberry ») announced that GBL had crossed the threshold of 3% of voting rights in the company. The investment in Burberry is aligned with GBL’s portfolio diversification strategy. At 31 March 2017, GBL held 3.0% of the capital of this company, representing a market value of EUR 266 million. Listed on the London Stock Exchange, Burberry has a market capitalisation of around EUR 9 billion at 31 March 2017. Burberry, a luxury British brand, specialises in the design, manufacture and marketing of high-end clothing and accessories. These products are distributed worldwide through its own stores, its website (www.burberry.com) and its network of third party retailers. Burberry employs almost 11,000 people and its turnover for the 2015-2016 financial year stood at around GBP 2.5 billion.

  • 2017 Acquisition

    Increase of voting rights in Pernod Ricard

    On 21 February 2017, GBL announced that it holds 10.6% of voting rights in Pernod Ricard (for a stake in capital of 7.5%). This passive crossing of the 10% threshold is the result of the allocation of double voting rights.

  • 2017 Sale

    Sale of the stake in Golden Goose

    In February 2017, ECP III signed an agreement in relation to the disposal of its majority stake in Golden Goose, an Italian designer of contemporary footwear, clothing and accessories. This transaction, completed at the beginning of March 2017, generated a net consolidated capital gain on disposal of EUR 112 million (GBL’s share).

  • 2017 Sale

    Further divestment of ENGIE

    On 7 February 2017, GBL redeemed in cash the balance of the bonds exchangeable into ENGIE shares, i.e. an amount of EUR 306 million. During the first quarter of 2017, GBL also sold the balance of ENGIE shares underlying the bonds exchangeable into ENGIE shares (i.e. 11.9 million shares or 0.5% of the capital for EUR 145 million), generating a consolidated gain of EUR 1 million. GBL’s residual stake in ENGIE therefore stands at 0.1% of the capital at 30 June 2017 (or 2 million shares).

  • 2017 Acquisition

    Acquisition of a stake in Ipackchem by Sagard

    In February 2017, Sagard 3 acquired a stake in Ipackchem, one of the global leaders in the manufacturing of “barrier” packaging, whose products are mainly used in the transport and storage of aromas, fragrances and agrochemical products for which permeability, contamination and evaporation constraints are critical.

  • 2017 Acquisition

    First closing of the new investment fund KCO IV from Kartesia

    In 2016, Kartesia launched a new investment fund, KCO IV, in which Sienna Capital is committed for EUR 150 million. The first closing took place on 22 February 2017. At 30 September 2017, the total fund commitment amounts to EUR 770 million and KCO IV is invested at around 34%.